Modified to Modular FR Severe Bone Loss Trauma
by Sulzermedica
510(k) K002324
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK002324 | Date24 Aug 2000 | StatusActive |
Recalls
-
- Terminated Z-0861-2012
Fractured tips: Any use of force in a certain direction to the flat side of the instrument may result in fracturing of the mating geometry, creating the potential for metal debris at the surgical site.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JDI
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3350
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
This device is a prosthesis, hip, semi-constrained, metal/polymer, cemented, as defined in the regulatory classification. It is intended for use in orthopedic applications involving severe bone loss trauma.
It was cleared via FDA 510(k) process under K002324, with a decision date of August 24, 2000. The device is classified under product code JDI and reviewed by the Orthopedic advisory committee. It is supplied as a cemented hip prosthesis for use in trauma cases with severe bone loss.
Other devices from Sulzermedica
Questions
AI-generated answers, 1 Oct 2026
What is the MODIFIED TO MODULAR FR SEVERE BONE LOSS TRAUMA device used for?
This device is a cemented hip prosthesis intended for orthopedic applications involving severe bone loss trauma, providing semi-constrained stability with metal/polymer articulation for patients requiring reconstruction after traumatic bone deficiency.
How is the MODIFIED TO MODULAR FR SEVERE BONE LOSS TRAUMA prosthesis supplied and is it reusable?
The device is supplied as a cemented hip prosthesis for single-use implantation in trauma cases with severe bone loss; it is not designed for reuse due to wear, sterilization constraints, and regulatory classification as a permanent implant.
What regulatory pathway cleared the MODIFIED TO MODULAR FR SEVERE BONE LOSS TRAUMA device and when?
The device received FDA 510(k) clearance under K002324 on August 24, 2000, following a determination of substantial equivalence to a predicate device, as documented in its decision description and clearance type.